[{"address1": "11711 N. Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "(317) 659-0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 38, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Kent Hawryluk MBA", "age": 55, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 571200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 578000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven J. Prestrelski M.B.A., MBA, Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Gambino", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Graham", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Salomon  Azoulay", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Dorato DABT, Ph.D.", "title": "Sr. Vice President of Discovery & Non-Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.83, "open": 11.99, "dayLow": 10.975, "dayHigh": 12.3099, "regularMarketPreviousClose": 11.83, "regularMarketOpen": 11.99, "regularMarketDayLow": 10.975, "regularMarketDayHigh": 12.3099, "payoutRatio": 0.0, "forwardPE": -4.718884, "volume": 114801, "regularMarketVolume": 114801, "averageVolume": 302076, "averageVolume10days": 391310, "averageDailyVolume10Day": 391310, "bid": 8.82, "ask": 14.15, "bidSize": 2, "askSize": 2, "marketCap": 367424320, "fiftyTwoWeekLow": 8.631, "fiftyTwoWeekHigh": 27.5, "fiftyDayAverage": 14.7486, "twoHundredDayAverage": 18.6011, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 118475056, "profitMargins": 0.0, "floatShares": 13801728, "sharesOutstanding": 33417400, "sharesShort": 2799627, "sharesShortPriorMonth": 1674966, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0838, "heldPercentInsiders": 0.03243, "heldPercentInstitutions": 0.9863, "shortRatio": 9.71, "impliedSharesOutstanding": 33417400, "bookValue": 8.131, "priceToBook": 1.3522322, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -55179000, "trailingEps": -1.65, "forwardEps": -2.33, "enterpriseToEbitda": -1.996, "52WeekChange": -0.49978858, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 10.995, "targetHighPrice": 44.0, "targetLowPrice": 30.0, "targetMeanPrice": 37.25, "targetMedianPrice": 37.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 277063008, "totalCashPerShare": 8.291, "ebitda": -59348000, "totalDebt": 210000, "quickRatio": 25.451, "currentRatio": 25.748, "debtToEquity": 0.077, "operatingCashflow": -49790000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1740170886, "shortName": "MBX Biosciences, Inc.", "longName": "MBX Biosciences, Inc.", "regularMarketChangePercent": -7.0583262, "regularMarketPrice": 10.995, "marketState": "REGULAR", "fiftyDayAverageChange": -3.7536001, "fiftyDayAverageChangePercent": -0.25450552, "twoHundredDayAverageChange": -7.606101, "twoHundredDayAverageChangePercent": -0.40890595, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "regularMarketChange": -0.83500004, "regularMarketDayRange": "10.975 - 12.3099", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 302076, "fiftyTwoWeekLowChange": 2.3640003, "fiftyTwoWeekLowChangePercent": 0.2738965, "fiftyTwoWeekRange": "8.631 - 27.5", "fiftyTwoWeekHighChange": -16.505001, "fiftyTwoWeekHighChangePercent": -0.6001819, "fiftyTwoWeekChangePercent": -49.97886, "earningsTimestampStart": 1730984403, "earningsTimestampEnd": 1730984403, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.65, "epsForward": -2.33, "epsCurrentYear": -13.24512, "priceEpsCurrentYear": -0.83011705, "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]